Recurrent Respiratory Papillomatosis - 14 Studies Found
Recruiting |
: Avelumab for People With Recurrent Respiratory Papillomatosis :
|
Recruiting |
: Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement : Recurrent Respiratory Papillomatosis : 2015-12-10 : Drug: Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks on day 1 of eac |
Active, not recruiting |
: Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis : Squamous Papilloma of the Larynx : 2011-06-16 : Biological: Silgard vaccination with tetravalent antiviral vaccine |
Withdrawn |
: Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease :
: 2008-08-12 : |